Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-002277

President and CEO gave up 59,765 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Blume-Jensen Peter · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-14 Shares withheld for taxes : show line 1 in the form −59,765 $7.02 $419,550 2,502,129 D
Loading xslF345X05/form4.xml…